132 related articles for article (PubMed ID: 17268152)
21. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
[TBL] [Abstract][Full Text] [Related]
22. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut.
Shikina T; Hiroi T; Iwatani K; Jang MH; Fukuyama S; Tamura M; Kubo T; Ishikawa H; Kiyono H
J Immunol; 2004 May; 172(10):6259-64. PubMed ID: 15128814
[TBL] [Abstract][Full Text] [Related]
23. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
Kunisawa J; Gohda M; Kiyono H
Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
[TBL] [Abstract][Full Text] [Related]
24. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
25. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
26. [The development of mucosal vaccine using bacterial function for targeting mucosal tissues].
Suzuki H; Kondoh M; Yagi K; Kiyono H; Kunisawa J
Yakugaku Zasshi; 2014; 134(5):629-34. PubMed ID: 24790045
[TBL] [Abstract][Full Text] [Related]
27. [Properties of mucosal antibodies].
Quan C; Decroix N; Bouvet JP
J Soc Biol; 2001; 195(2):119-24. PubMed ID: 11723823
[TBL] [Abstract][Full Text] [Related]
28. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract.
McGhee JR; Xu-Amano J; Miller CJ; Jackson RJ; Fujihashi K; Staats HF; Kiyono H
Reprod Fertil Dev; 1994; 6(3):369-79. PubMed ID: 7831485
[TBL] [Abstract][Full Text] [Related]
29. NALT- versus Peyer's-patch-mediated mucosal immunity.
Kiyono H; Fukuyama S
Nat Rev Immunol; 2004 Sep; 4(9):699-710. PubMed ID: 15343369
[TBL] [Abstract][Full Text] [Related]
30. [Recent progress for the development of mucosal vaccine].
Nochi T; Kiyono H
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1089-95. PubMed ID: 21089546
[No Abstract] [Full Text] [Related]
31. Targeting of mucosal vaccines to Peyer's patch M cells.
Frey A; Neutra MR
Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
[TBL] [Abstract][Full Text] [Related]
32. New horizon of mucosal immunity and vaccines.
Takahashi I; Nochi T; Yuki Y; Kiyono H
Curr Opin Immunol; 2009 Jun; 21(3):352-8. PubMed ID: 19493665
[TBL] [Abstract][Full Text] [Related]
33. The mucosal immunologic network.
Bienenstock J
Ann Allergy; 1984 Dec; 53(6 Pt 2):535-40. PubMed ID: 6391284
[TBL] [Abstract][Full Text] [Related]
34. Regulation of IgA synthesis at mucosal surfaces.
Fagarasan S; Honjo T
Curr Opin Immunol; 2004 Jun; 16(3):277-83. PubMed ID: 15134775
[TBL] [Abstract][Full Text] [Related]
35. The gastrointestinal mucosal immune system.
James SP
Dig Dis; 1993; 11(3):146-56. PubMed ID: 8370141
[TBL] [Abstract][Full Text] [Related]
36. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies.
Shalaby WS
Clin Immunol Immunopathol; 1995 Feb; 74(2):127-34. PubMed ID: 7828366
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
